Latest News

Sanofi, GSK announce delay in Covid vaccine until end of 2021

France-based Sanofi and Britain’s GSK have announced on Friday that their coronavirus vaccines will face a delay and will be available until the end of 2021 after temporary results had shown a low immune response in older people.

The announcement from the companies is a huge setback in efforts to tackle the COVID-19 pandemic.

The companies said the delay in their adjuvanted recombinant protein-based COVID-19 vaccine programme was to “improve immune response in older adults.”

The vaccine’s potential availability had been pushed back “from mid-2021 to Q4 2021,” they said in a statement.

Meanwhile, American pharmaceutical giant Pfizer and its German partner BioNTech have said their vaccine had proven 90 percent effectiveness in curtailing coronavirus infections in ongoing Phase 3 trials involving more than 40,000 people.

On Thursday, US experts voted to recommend granting emergency approval for the Pfizer-BioNTech vaccine, the move will pave the way for America to become the next country to go ahead with mass immunisation after the UK. Canada, Bahrain, and Saudi Arabia.

Saman Siddiqui

Saman Siddiqui, A freelance journalist with a Master’s Degree in Mass Communication and MS in Peace and Conflict Studies. Associated with the media industry since 2006. Experience in various capacities including Program Host, Researcher, News Producer, Documentary Making, Voice Over, Content Writing Copy Editing, and Blogging, and currently associated with OyeYeah since 2018, working as an Editor.

Related Articles

Leave a Reply

Your email address will not be published.

four + 7 =

Back to top button